# LYT-300 in Healthy Volunteers

> **NCT05129865** · PHASE1,PHASE2 · COMPLETED · sponsor: **PureTech** · enrollment: 186 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** LYT-300
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05129865
- **Lead sponsor:** PureTech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-07
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-23
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129865, "LYT-300 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05129865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*